Fig. 3From: Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapyHITAS scores between survivors and non-survivors, and the ROC curves of HITAS scores. A HITAS scores of non-survivors were higher than those of survivors in the training cohort. B HITAS scores of non-survivors were higher than those of survivors in the validation cohort. C HITAS scores of non-survivors were higher than those of survivors in the entire cohort. D ROC curves of HITAS scores in the training group (AUC 0.88). E ROC curves of HITAS scores in the validation group (AUC 0.87). F ROC curves of HITAS scores in the entire cohort (AUC 0.87)Back to article page